Joint Formulary & PAD

Hyoscine butylbromide - Excessive secretions in palliative care

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Subcutaneous infusion
  • Subcutaneous injection (sc)
  • Tablets
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Hyoscine butylbromide
Indication :
Excessive secretions in palliative care
Group Name :
Keywords :
Brand Names Include :
Buscopan
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Hyoscine butylbromide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Excessive secretions in palliative care.

Committee Recommendations (0)

  • No records returned.